Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells

Tumor Necrosis Factor-α (TNF-α), a secreted cytokine, plays an important role in inflammatory diseases and immune disorders, and is a potential target for drug development. The traditional assays for detecting TNF-α, enzyme linked immunosorbent assay (ELISA) and radioimmunoassay, are not suitable for the large size compound screens. Both assays suffer from a complicated protocol, multiple plate wash steps and/or excessive radioactive waste. A simple and quick measurement of TNF-α production in a cell based assay is needed for high throughput screening to identify the lead compounds from the compound library. We have developed and optimized two homogeneous TNF-α assays using the HTRF (homogeneous time resolved fluorescence) and AlphaLISA assay formats. We have validated the HTRF based TNF-α assay in a 1536-well plate format by screening a library of 1280 pharmacologically active compounds. The active compounds identified from the screen were confirmed in the AlphaLISA TNF-α assay using a bead-based technology. These compounds were also confirmed in a traditional ELISA assay. From this study, several beta adrenergic agonists have been identified as TNF-α inhibitors. We also identified several novel inhibitors of TNF-α, such as BTO-1, CCG-2046, ellipticine, and PD 169316. The results demonstrated that both homogeneous TNF-α assays are robust and suitable for high throughput screening.

[1]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Paul,et al.  Modulating TNF-α signaling with natural products , 2006 .

[3]  Genhong Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[4]  S. Targan,et al.  TNF-α antagonists for the treatment of Crohn’s disease , 2000 .

[5]  J. Talmadge,et al.  Molecular pharmacology of the beta-adrenergic receptor on THP-1 cells. , 1993, International journal of immunopharmacology.

[6]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[7]  Christopher Prendergast,et al.  The Modern Classic , 2007 .

[8]  E. Trinquet,et al.  HTRF: A Technology Tailored for Drug Discovery –A Review of Theoretical Aspects and Recent Applications , 2009, Current chemical genomics.

[9]  N. Mackman,et al.  Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. , 1997, The Journal of biological chemistry.

[10]  A. Briggs.  IV. Thomas Attwood and the Economic Background of the Birmingham Political Union , 1948 .

[11]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[12]  J. Ebert.  Collection of Essays , 1967 .

[13]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Eglen,et al.  The Use of AlphaScreen Technology in HTS: Current Status , 2008, Current chemical genomics.

[15]  G. Hartmann,et al.  Taming TNF: strategies to restrain this proinflammatory cytokine. , 1997, Immunology today.

[16]  A. Paul,et al.  Modulating TNF-alpha signaling with natural products. , 2006, Drug discovery today.

[17]  L. Liu,et al.  Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[18]  J. Steer,et al.  Sesquiterpene Lactone Parthenolide Blocks Lipopolysaccharide‐Induced Osteolysis Through the Suppression of NF‐κB Activity , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  B. van Weemen,et al.  Immunoassay using antigen—enzyme conjugates , 1971, FEBS letters.

[20]  M. Nirenberg,et al.  A Cell-Based β-Lactamase Reporter Gene Assay for the CREB Signaling Pathway , 2009, Current chemical genomics.

[21]  J. G. Griffith,et al.  Government and Law , 1981 .

[22]  C. Dinarello,et al.  Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors , 1991, The Journal of experimental medicine.

[23]  Dr Ferdiye Taner,et al.  The enzyme-linked immunosorbent assay (ELISA). , 1976, Bulletin of the World Health Organization.

[24]  C. Tilly,et al.  Population in History. , 1966 .

[25]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[26]  Min-jung Park,et al.  Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation. , 2008, European Journal of Pharmacology.

[27]  J. Nicolas.  Secretary of state for the home department , 2010 .

[28]  S. Bhattacharyya,et al.  Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[29]  S. Woolley.  The Personnel of the Parliament of 1833 , 1938 .

[30]  S. Tsao,et al.  Targeting NF-κB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer , 2009, Molecular Cancer Therapeutics.

[31]  Ruili Huang,et al.  Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.

[32]  N. Mackman,et al.  Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells , 1997, The Journal of Biological Chemistry.

[33]  K. Kreuzer,et al.  Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases. , 1990, The Journal of biological chemistry.

[34]  K. Steger,et al.  Development of a HTRF® Kinase Assay for Determination of Syk Activity , 2008, Current chemical genomics.

[35]  R. Danner,et al.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents , 1991, The Journal of experimental medicine.

[36]  Henry Pelling.  First Lord of the Admiralty , 1989 .

[37]  F. Hernández-Sánchez,et al.  NF-κB signaling blockade by Bay 11-7085 during early cardiac morphogenesis induces alterations of the outflow tract in chicken heart , 2006, Apoptosis.

[38]  F. Khuri,et al.  A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides , 2008, Current chemical genomics.

[39]  G. Himmelfarb.  The Writing of Social History: Recent Studies of 19th Century England , 1971, Journal of British Studies.

[40]  F. Mather,et al.  Lord John Russell. , 1972 .

[41]  Kazuhiko Nakamura,et al.  Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. , 2006, World journal of gastroenterology.

[42]  S. Berson,et al.  Assay of Plasma Insulin in Human Subjects by Immunological Methods , 1959, Nature.

[43]  A. Straight,et al.  Substance Abuse: Resurgence of Teen Inhalant Use , 2005, Environmental health perspectives.

[44]  A. Ishisaki,et al.  Interleukin (IL)‐17 enhances tumor necrosis factor‐α‐stimulated IL‐6 synthesis via p38 mitogen‐activated protein kinase in osteoblasts , 2004, Journal of cellular biochemistry.

[45]  Philip A. M. Taylor.  The industrial revolution in Britain: triumph or disaster? , 1969 .

[46]  S. Targan,et al.  TNF-alpha antagonists for the treatment of Crohn's disease. , 2000, Expert opinion on pharmacotherapy.

[47]  R. Ye.  β-Adrenergic agonists regulate NF-κB activation through multiple mechanisms , 2000 .

[48]  E. Engvall,et al.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. , 1971, Immunochemistry.